OtherContinuing Education
Molecular and Metabolic Imaging of Atherosclerosis
John R. Davies, James H. Rudd and Peter L. Weissberg
Journal of Nuclear Medicine November 2004, 45 (11) 1898-1907;
John R. Davies
James H. Rudd
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Molecular and Metabolic Imaging of Atherosclerosis
John R. Davies, James H. Rudd, Peter L. Weissberg
Journal of Nuclear Medicine Nov 2004, 45 (11) 1898-1907;
Related Articles
Cited By...
- 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients
- Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types
- Molecular Imaging of Atherosclerotic Plaque with 64Cu-Labeled Natriuretic Peptide and PET
- Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti-LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque
- Noninvasive Screening for Coronary Atherosclerosis and Silent Ischemia in Asymptomatic Type 2 Diabetic Patients: Is it Appropriate and Cost-Effective?
- Carotid Stenting for Asymptomatic Carotid Stenosis: Trial It
- Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the rotterdam study.
- Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications
- A Novel Approach to Multipinhole SPECT for Myocardial Perfusion Imaging
- The contribution of PET/CT to improved patient management